- Home
- TNL vs RLAY Comparison
TNL vs RLAY Comparison
Compare TNL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNL | RLAY |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TNL | RLAY |
|---|---|---|
| Price | $79.28 | $19.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $84.00 | $19.50 |
| AVG Volume (30 Days) | 833.7K | ★ 2.4M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.80% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 2.94 | N/A |
| Revenue | ★ $4,021,000,000.00 | $15,355,000.00 |
| Revenue This Year | $3.56 | N/A |
| Revenue Next Year | $3.55 | $324.03 |
| P/E Ratio | $26.55 | ★ N/A |
| Revenue Growth | 4.06 | ★ 53.44 |
| 52 Week Low | $57.79 | $3.03 |
| 52 Week High | $81.00 | $20.79 |
Technical Indicators
Market Signals| Indicator | TNL | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 59.61 |
| Support Level | $71.58 | $18.02 |
| Resistance Level | $81.00 | $20.59 |
| Average True Range (ATR) | 2.22 | 0.99 |
| MACD | 0.31 | -0.09 |
| Stochastic Oscillator | 99.71 | 79.10 |
Price Performance
Historical ComparisonAbout TNL Travel Leisure Co.
Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.